Carotid Artery Stenting: Evolution, Evidence, and Contemporary Practice in the Era of Intensive Medical Therapy

Read full text
Authors: Sakshi Dixit, FNU Anamika, Anmol Multani, Akiva Rosenzveig, Bargavi Kathirvel, Suprita Degala, Manvitha Thalamati, Lee Kirksey, Christopher Bajzer, Daniel Raskin, Aravinda Nanjundappa
Cited by: 1
References: 70

Abstract

Carotid artery stenosis remains a major cause of ischemic stroke worldwide, and its management continues to evolve in parallel with advances in surgical, endovascular, and medical therapies. Carotid endarterectomy (CEA) was established as the standard of care for symptomatic high-grade stenosis following landmark randomized trials, while carotid artery stenting (CAS) subsequently emerged as a less invasive alternative for appropriately selected patients. This review aims to summarize the historical evolution of carotid artery stenting, critically appraise evidence from major clinical trials comparing CAS and CEA, and examine contemporary practice patterns in the era of intensive medical therapy. A comprehensive review of randomized trials, registries, guideline statements, and recent literature was performed to synthesize current evidence regarding procedural outcomes, patient selection, and emerging technologies, including transcarotid artery revascularization (TCAR). Large, randomized trials have demonstrated comparable long-term composite outcomes between CAS and CEA in selected patients, although peri-procedural risk profiles differ, with higher stroke risk observed after CAS and higher myocardial infarction rates after CEA. Technological advancements in embolic protection devices, stent platforms, and alternative access strategies have further refined endovascular approaches. Concurrently, improvements in intensive medical therapy-including lipid-lowering, antiplatelet therapy, blood pressure control, smoking cessation, and lifestyle modification-have substantially reduced overall stroke risk, particularly in asymptomatic patients. In the contemporary era, optimal stroke prevention requires individualized, multidisciplinary decision-making that integrates symptom status, anatomical complexity, comorbid conditions, procedural expertise, and sustained long-term vascular risk factor management following revascularization.

Fields of Study & Subjects

Cerebrovascular and Carotid Artery Diseases Moyamoya disease diagnosis and treatment Acute Ischemic Stroke Management

Publication details

Journal / source
Life
Publisher
MDPI AG
Volume
16
Issue
4
Pages
601–601
Publication date
4 April 2026
Language
EN